Press release
Demand for Biologics Contract Manufacturing Market is forecasted to reach a value of US$ 51.81 billion by 2034
The biologics contract manufacturing market (生物製剤受託製造市場) is projected to reach a size of US$ 21.19 billion in 2024, according to a recent industry report by Fact.MR. The global demand for biologics contract manufacturing is expected to grow at a significant compound annual growth rate (CAGR) of 9.4%, reaching a market value of US$ 51.81 billion by 2034.The biologics contract manufacturing market is experiencing robust growth, driven by the increasing demand for biopharmaceuticals, advancements in biotechnology, and the complexities of in-house manufacturing. Biologics, which include vaccines, monoclonal antibodies, and cell therapies, are highly complex molecules that require specialized manufacturing processes. Contract manufacturing organizations (CMOs) play a crucial role in the production of biologics, providing expertise, capacity, and flexibility to biopharmaceutical companies.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9572
Market Dynamics
One of the key drivers of the biologics contract manufacturing market is the growing pipeline of biologics. As more biopharmaceutical companies focus on developing biologics to address unmet medical needs, the demand for contract manufacturing services is expected to increase. Additionally, the complexity of biologics production, including the need for specialized equipment and expertise, makes outsourcing an attractive option for many companies.
Another important factor driving market growth is the cost-effectiveness of contract manufacturing. Establishing and maintaining a biologics manufacturing facility can be extremely expensive, requiring significant investments in infrastructure, equipment, and personnel. Outsourcing allows companies to avoid these costs and focus on their core competencies, such as research and development and marketing.
List of Key Companies Profiled in The Report
Lonza Group AG
BioXcellence
Samsung Biologics
AbbVie CM
Fujifilm Diosynth Biotechnologies
AGC Biologics
Patheon N.V.
Ajinomoto Bio-Pharma
Emergent BioSolutions Inc.
Avid Bioservices, Inc.
Rentschler Biotechnologies GmbH
KBI Biopharma
Merck KGaA
Novasep
Therapure Biopharma Inc.
Abzena Plc.
ProBioGen AG
Market Future Outlook
The biologics contract manufacturing market is poised for continued growth in the coming years. Factors such as the increasing prevalence of chronic diseases, advancements in biotechnology, and the growing demand for personalized medicine are expected to drive market expansion. Additionally, the COVID-19 pandemic has highlighted the importance of biologics in healthcare, further fueling demand for contract manufacturing services.
Market Insights
North America is the largest market for biologics contract manufacturing, driven by the presence of a large number of biopharmaceutical companies and a well-developed healthcare infrastructure. Europe is also a significant market, with countries like Germany, Switzerland, and the UK leading the way in biologics manufacturing. Asia Pacific is expected to witness the fastest growth, fueled by increasing investments in biotechnology and a growing demand for biologics in countries like China and India.
Want Full Report? Enquire Here- https://www.factmr.com/report/biologics-contract-manufacturing-market
Recent Developments
Major players in the market are emphasizing their global distribution networks to drive revenue growth. Additionally, they are investing in supply chain management, new developments, and product quality.
For example, in November 2021, Abzena Limited partnered with BiVictriX Therapeutics Plc. to manufacture BiVictriX's antibody-drug conjugates (ADCs).
Explore More Related Studies Published by Fact.MR Research:
Long-Acting Insulin Market (持効型インスリン市場): https://www.factmr.com/report/long-acting-insulin-market
Biological Drug Market (生物学的製剤市場): https://www.factmr.com/report/biological-drug-market
Monoclonal Antibodies Market (モノクローナル抗体市場): https://www.factmr.com/report/monoclonal-antibodies-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Demand for Biologics Contract Manufacturing Market is forecasted to reach a value of US$ 51.81 billion by 2034 here
News-ID: 3389961 • Views: …
More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…

Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…

Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…

Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Biologics
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar …
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market
What is the…
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Biologics Contract Manufacturing Market - Strategic biologics manufacturing part …
Newark, New Castle, USA: The "Biologics Contract Manufacturing Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Biologics Contract Manufacturing Market: https://www.growthplusreports.com/report/biologics-contract-manufacturing-market/8606
This latest report researches the industry structure,…